Quince Therapeutics, Inc. - QNCX

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 27
Latest filed: Sep 14, 2026
Form Count
8-K 14
SCHEDULE 13G 5
8-K/A 3
4 3
SCHEDULE 13G/A 2

Latest files

Filed Form Report period Accession SEC
Sep 14, 2026 8-K Sep 08, 2026 0001193125-26-390652 View
Sep 04, 2026 8-K Aug 31, 2026 0001193125-26-382838 View
Aug 27, 2026 8-K Aug 23, 2026 0001193125-26-371389 View
Aug 17, 2026 8-K Aug 17, 2026 0001193125-26-353141 View
Aug 14, 2026 SCHEDULE 13G 0001193125-26-352966 View
Aug 14, 2026 SCHEDULE 13G/A 0001104659-26-097291 View
Aug 14, 2026 SCHEDULE 13G 0001172661-26-003692 View
Aug 14, 2026 8-K Aug 14, 2026 0001193125-26-350568 View
Aug 14, 2026 SCHEDULE 13G 0001172661-26-003433 View
Aug 04, 2026 SCHEDULE 13G 0002050709-26-000021 View
Jul 31, 2026 8-K Jul 29, 2026 0001193125-26-328784 View
Jul 30, 2026 8-K/A May 17, 2026 0001193125-26-324786 View
Jun 26, 2026 8-K/A Jun 26, 2026 0001193125-26-285572 View
Jun 26, 2026 8-K Jun 26, 2026 0001193125-26-284089 View
Jun 15, 2026 4 Jun 11, 2026 0000912282-26-000830 View
Jun 15, 2026 4 Jun 11, 2026 0000912282-26-000832 View
Jun 11, 2026 8-K Jun 11, 2026 0001193125-26-267862 View
Jun 11, 2026 4 May 18, 2026 0001346566-26-000004 View
Jun 10, 2026 SCHEDULE 13G 0001104659-26-072388 View
May 21, 2026 8-K May 20, 2026 0001193125-26-234858 View
May 18, 2026 8-K/A May 17, 2026 0001193125-26-228956 View
May 18, 2026 8-K May 17, 2026 0001193125-26-228133 View
May 15, 2026 SCHEDULE 13G/A 0001104659-26-062688 View
Apr 28, 2026 8-K Apr 27, 2026 0001193125-26-187243 View
Apr 22, 2026 8-K Apr 22, 2026 0001193125-26-170572 View
Apr 09, 2026 8-K Apr 09, 2026 0001193125-26-149021 View
Mar 30, 2026 8-K Mar 27, 2026 0001193125-26-130489 View